Trial · NCT01735422
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ovulation rate | Day 4 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Primary | Ratio of ruptured follicles per follicle with diameter greater than or equal to (>=) 15 millimeter (mm) | Day 4 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Primary | Number of follicles with diameter greater than or equal to (>=) 11 millimeter (mm) | Day 4 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Primary | Ratio of ruptured follicles per follicle with diameter greater than or equal to (>=) 11 millimeter (mm) | Day 4 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Percentage of participants with mono-follicular ovulation | Day 4 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Number of participants with biochemical pregnancy | Day 25-30 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Serum estradiol (E2) levels | Day 1, 2 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Serum androstenedione levels | Day 1, 2 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Serum total renin levels | Day 1, 2 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Serum vascular endothelial growth factor (VEGF) levels | Day 1, 2 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Endometrial thickness | Day 0, 1, 2, 3, 4 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Number of participants with clinical pregnancy | Day 25-30 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) | |
| Secondary | Serum progesterone (P4) levels | Day 1, 2 and 6-9 post r-hLH/u-hCG day (end of stimulation cycle [approximately 28 days]) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01735422/registered